tiprankstipranks
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Class H (HK:0874)
:0874
Hong Kong Market
0874
Guangzhou Baiyunshan Pharmaceutical Holdings Company
RESEARCH TOOLSreports
Want to see HK:0874 full AI Analyst Report?

Guangzhou Baiyunshan Pharmaceutical Holdings Company (0874) Ratios

0 Followers

Guangzhou Baiyunshan Pharmaceutical Holdings Company Ratios

HK:0874's free cash flow for Q1 2026 was ¥0.20. For the 2026 fiscal year, HK:0874's free cash flow was decreased by ¥ and operating cash flow was ¥0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.60 1.57 1.48 1.55 1.53
Quick Ratio
 1.29 1.24 1.16 1.23 1.24
Cash Ratio
 0.30 0.38 0.47 0.59 0.60
Solvency Ratio
 0.07 0.09 0.08 0.12 0.11
Operating Cash Flow Ratio
 0.05 <0.01 0.09 0.11 0.19
Short-Term Operating Cash Flow Coverage
 0.11 0.01 0.38 0.53 0.82
Net Current Asset Value
¥ 17.20B¥ 18.14B¥ 13.85B¥ 14.07B¥ 16.04B
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.24 0.15 0.15 0.15
Debt-to-Equity Ratio
 0.59 0.55 0.34 0.34 0.36
Debt-to-Capital Ratio
 0.37 0.35 0.26 0.25 0.26
Long-Term Debt-to-Capital Ratio
 0.11 0.08 0.07 0.09 0.05
Financial Leverage Ratio
 2.27 2.24 2.28 2.25 2.33
Debt Service Coverage Ratio
 0.17 0.19 0.45 0.68 0.61
Interest Coverage Ratio
 8.04 7.26 8.60 11.48 11.68
Debt to Market Cap
 0.63 0.79 0.43 0.34 0.31
Interest Debt Per Share
 14.70 12.99 7.87 7.47 7.30
Net Debt to EBITDA
 1.69 1.46 -1.20 -1.48 -1.78
Profitability Margins
Gross Profit Margin
16.00%15.18%16.70%18.79%18.76%
EBIT Margin
4.26%4.01%5.37%7.36%7.74%
EBITDA Margin
4.76%5.24%6.54%8.59%8.79%
Operating Profit Margin
4.13%4.01%4.80%6.78%7.17%
Pretax Profit Margin
4.67%4.76%4.81%6.77%7.12%
Net Profit Margin
3.75%3.85%3.78%5.37%5.60%
Continuous Operations Profit Margin
3.86%3.95%4.00%5.64%6.01%
Net Income Per EBT
80.33%80.84%78.60%79.36%78.65%
EBT Per EBIT
113.12%118.96%100.31%99.80%99.39%
Return on Assets (ROA)
3.28%3.44%3.47%5.16%5.31%
Return on Equity (ROE)
7.70%7.69%7.90%11.61%12.37%
Return on Capital Employed (ROCE)
6.62%6.65%8.41%12.09%13.62%
Return on Invested Capital (ROIC)
3.98%4.01%5.76%8.51%9.34%
Return on Tangible Assets
3.44%3.61%3.65%5.44%5.59%
Earnings Yield
7.92%11.23%10.20%12.43%12.01%
Efficiency Ratios
Receivables Turnover
 2.90 3.22 3.67 3.85 3.52
Payables Turnover
 4.98 5.12 3.83 3.91 3.84
Inventory Turnover
 5.29 4.87 4.88 5.33 5.39
Fixed Asset Turnover
 9.29 9.01 9.45 10.05 10.78
Asset Turnover
 0.87 0.89 0.92 0.96 0.95
Working Capital Turnover Ratio
 3.36 3.66 3.89 3.83 3.52
Cash Conversion Cycle
 121.50 117.08 79.04 69.85 76.34
Days of Sales Outstanding
 125.78 113.43 99.53 94.72 103.56
Days of Inventory Outstanding
 69.06 74.98 74.85 68.49 67.73
Days of Payables Outstanding
 73.33 71.33 95.35 93.36 94.95
Operating Cycle
 194.84 188.41 174.38 163.21 171.29
Cash Flow Ratios
Operating Cash Flow Per Share
 1.21 0.16 2.12 2.52 4.31
Free Cash Flow Per Share
 0.45 -0.59 1.42 1.52 3.45
CapEx Per Share
 0.76 0.74 0.69 1.00 0.85
Free Cash Flow to Operating Cash Flow
 0.37 -3.76 0.67 0.60 0.80
Dividend Paid and CapEx Coverage Ratio
 0.60 0.10 1.02 1.28 2.43
Capital Expenditure Coverage Ratio
 1.59 0.21 3.05 2.52 5.06
Operating Cash Flow Coverage Ratio
 0.08 0.01 0.28 0.35 0.61
Operating Cash Flow to Sales Ratio
 0.03 <0.01 0.05 0.05 0.10
Free Cash Flow Yield
1.95%-3.69%8.33%7.59%17.01%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 12.50 8.90 9.80 8.05 8.32
Price-to-Sales (P/S) Ratio
 0.47 0.34 0.37 0.43 0.47
Price-to-Book (P/B) Ratio
 0.93 0.68 0.77 0.93 1.03
Price-to-Free Cash Flow (P/FCF) Ratio
 50.79 -27.11 12.01 13.18 5.88
Price-to-Operating Cash Flow Ratio
 18.76 102.08 8.07 7.95 4.72
Price-to-Earnings Growth (PEG) Ratio
 1.30 3.10 -0.33 3.93 1.27
Price-to-Fair Value
 0.93 0.68 0.77 0.93 1.03
Enterprise Value Multiple
 12.86 8.00 4.47 3.55 3.53
Enterprise Value
 43.49B 31.63B 21.89B 23.02B 21.95B
EV to EBITDA
 11.65 8.00 4.47 3.55 3.53
EV to Sales
 0.55 0.42 0.29 0.30 0.31
EV to Free Cash Flow
 59.98 -33.14 9.46 9.30 3.91
EV to Operating Cash Flow
 22.15 124.77 6.36 5.61 3.14
Tangible Book Value Per Share
 23.25 22.83 20.75 20.08 18.44
Shareholders’ Equity Per Share
 24.33 23.25 22.08 21.48 19.72
Tax and Other Ratios
Effective Tax Rate
 0.17 0.17 0.17 0.17 0.16
Revenue Per Share
 48.26 46.40 46.13 46.45 43.55
Net Income Per Share
 1.81 1.79 1.74 2.49 2.44
Tax Burden
 0.80 0.81 0.79 0.79 0.79
Interest Burden
 1.10 1.19 0.90 0.92 0.92
Research & Development to Revenue
 <0.01 <0.01 0.01 0.01 0.01
SG&A to Revenue
 0.10 0.10 0.04 <0.01 <0.01
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.87 0.09 1.15 0.96 1.65
Currency in CNY